Skip Navigation


JAC Advance Access originally published online on November 12, 2005
Journal of Antimicrobial Chemotherapy 2005 56(6):1042-1046; doi:10.1093/jac/dki386
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/6/1042    most recent
dki386v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hope, R.
Right arrow Articles by Livermore, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hope, R.
Right arrow Articles by Livermore, D. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines

R. Hope, M. Warner, S. Mushtaq, M. E. Ward, T. Parsons and D. M. Livermore*

Antibiotic Resistance Monitoring Reference Laboratory, Centre for Infections, Heath Protection Agency, 61 Colindale Avenue, London NW9 5HT, UK

Received 7 July 2005; returned 4 September 2005; revised 27 September 2005; accepted 28 September 2005


* Corresponding author. Tel: +44-02083277223; Fax: +44-02083276264; E-mail: david.livermore{at}hpa.org.uk

Background: Tigecycline is a minocycline derivative, belonging to a chemical class prone to oxidation and to medium-related effects on susceptibility. We therefore studied the effect of medium type and age on the tigecycline MICs found in broth and on agar by the Clinical Laboratory Standards Institute and British Society for Applied Chemotherapy methods.

Methods: MICs of tigecycline, minocycline and tetracycline were determined for 96 non-fastidious bacteria and 20 streptococci using Mueller–Hinton broth (MHB), Mueller–Hinton agar (MHA), Iso-Sensitest broth (ISB) and Iso-Sensitest agar (ISA) as: (i) freshly-prepared media; (ii) fresh media but with the antibiotic added 1 day before inoculation and (iii) media stored for 7 days before antibiotic addition and use.

Results: MICs of tigecycline in fresh MHB were up to two doubling dilutions higher than on or in MHA, ISA or ISB. Media with tigecycline or classical tetracyclines added a day before use gave raised MICs, though rarely by more than one dilution. MICs of tigecycline (less so classical tetracyclines) were increased in 7-day-old MHB or ISB, even though the antibiotic was freshly added. This latter effect was greatest for the most susceptible strains and was absent or much reduced for organisms with MICs ≥8 mg/L; it did not occur in the corresponding agar dilution tests. Addition of blood to MHB largely abrogated the effect, as did steaming the broth before adding the antibiotic.

Conclusions: The raised MICs of tigecycline in aged broth probably reflect inactivation by dissolved oxygen. This accords with the lack of any MIC increase in newly-steamed (i.e. degassed) MHB or on aged agar (which is melted at 100°C before use). Blood, which also abrogated the effect, may increase reducing capacity, protecting the tigecycline. At a practical level, broth MIC determinations for tigecycline should always employ fresh media.

Keywords: GAR-936 , BSAC , CLSI


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
P. Vaudaux, B. Fleury, A. Gjinovci, E. Huggler, M. Tangomo-Bento, and D. P. Lew
Comparison of Tigecycline and Vancomycin for Treatment of Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureus
Antimicrob. Agents Chemother., July 1, 2009; 53(7): 3150 - 3152.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
T. Kelesidis, D. E. Karageorgopoulos, I. Kelesidis, and M. E. Falagas
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
J. Antimicrob. Chemother., November 1, 2008; 62(5): 895 - 904.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
R. Hope, D. M. Livermore, G. Brick, M. Lillie, R. Reynolds, and on behalf of the BSAC Working Parties on Resistanc
Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06
J. Antimicrob. Chemother., November 1, 2008; 62(suppl_2): ii65 - ii74.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
V. Thamlikitkul and S. Tiengrim
Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp.
J. Antimicrob. Chemother., October 1, 2008; 62(4): 847 - 848.
[Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
A. Y. Peleg, H. Seifert, and D. L. Paterson
Acinetobacter baumannii: Emergence of a Successful Pathogen
Clin. Microbiol. Rev., July 1, 2008; 21(3): 538 - 582.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. Y. Peleg, J. Adams, and D. L. Paterson
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii
Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2065 - 2069.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.